Therapeutic Gene Editing Safety and Specificity
- 1 October 2017
- journal article
- review article
- Published by Elsevier in Hematology/Oncology Clinics of North America
- Vol. 31 (5) , 787-795
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- CRISPR/Cas9 systems targeting β-globin and CCR5 genes have substantial off-target activityNucleic Acids Research, 2013
- High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cellsNature Biotechnology, 2013
- RNA-Guided Human Genome Engineering via Cas9Science, 2013
- Genome-wide Translocation Sequencing Reveals Mechanisms of Chromosome Breaks and Rearrangements in B CellsCell, 2011
- Efficient design and assembly of custom TALEN and other TAL effector-based constructs for DNA targetingNucleic Acids Research, 2011
- Genome editing with engineered zinc finger nucleasesNature Reviews Genetics, 2010
- Frequent Endonuclease Cleavage at Off-target Locations In VivoMolecular Therapy, 2010
- Attenuation of Zinc Finger Nuclease Toxicity by Small-Molecule Regulation of Protein LevelsPLOS Genetics, 2009
- Expanding or Restricting the Target Site Repertoire of Zinc-finger Nucleases: The Inter-domain Linker as a Major Determinant of Target Site SelectivityMolecular Therapy, 2009
- An improved zinc-finger nuclease architecture for highly specific genome editingNature Biotechnology, 2007